British Phase 2 biotech developing a psilocybin-based therapy for depression.
Industry: Health Care
First Day Return: +70.6%
Industry: Health Care
IPO Data | |
---|---|
IPO File Date | 08/28/2020 |
Offer Price | $17.00 |
Price Range $14.00 - $16.00 | |
Offer Shares (mm) | 7.5 |
Deal Size ($mm) | $128 |
Lock-Up Date | IPO Pro Only |
Street Research | IPO Pro Only |
IPO Data | |
---|---|
IPO Date | 09/17/2020 |
Offer Price | IPO Intelligence Only |
Price Range | IPO Intelligence Only |
Offer Shares (mm) | IPO Intelligence Only |
Deal Size ($mm) | $128 |
Lock-Up Date | IPO Intelligence Only |
Street Research | IPO Intelligence Only |
Underwriters |
---|
IPO Intelligence Only |
Company Data | |
---|---|
Headquarters | Cheshire, United Kingdom |
Founded | 2015 |
Employees at IPO | 48 |
Website www.compasspathways.com |